FEROX STRATEGIES

Lobbying for ALEXION PHARMACEUTICALS, INC. · Rare Disease Pharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $60,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Health Issues

General issues related to the rare disease pharmaceutical ecosystem.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.